Teladoc Health, Inc. (TDOC) EV/Sales Ratio: 0.65x
Is Teladoc Health, Inc.’s EV/Sales ratio high or low?
Teladoc Health, Inc.'s EV/Sales ratio of 0.65x is 78% below its 5-year average of 2.92x, near the low end of its 5-year range (0.44x–19.58x).
As of Tuesday, June 23, 2026. 6.15% above its 12-month average of 0.61x.
TDOC EV/Sales Ratio Chart
TDOC Average EV/Sales Ratio Chart
TDOC Current vs Average EV/Sales Ratio Chart
TDOC EV/Sales Ratio Metrics
EV/SALES RATIO
0.65x
EV/SALES RATIO AVG TTM
0.61x
EV/SALES RATIO AVG 3Y
0.88x
EV/SALES RATIO AVG 5Y
1.38x
EV/SALES RATIO AVG 10Y
8.14x
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.15%
CURRENT VS 3Y AVG
-26.46%
CURRENT VS 5Y AVG
-52.76%
CURRENT VS 10Y AVG
-92.01%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TDOC Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.37B | 0.65x | 0.61x | 0.88x | 1.38x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.03B | 1.13x | 1.26x | 1.70x | 2.16x |
| Shoulder Innovations, Inc. (SI)vs › | $366.44M | 6.88x | 6.41x | 6.41x | 6.41x |
| TransMedics Group, Inc. (TMDX)vs › | $2.61B | 4.93x | 8.56x | 11.15x | 16.28x |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.02x | 0.35x | 0.71x | 3.53x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 3.62x | 4.59x | 4.20x | 4.23x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 3.26x | 3.42x | 3.66x | 4.56x |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | 0.38x | 0.23x | 0.31x | 0.45x |
| Tempus AI, Inc. (TEM)vs › | $8.35B | 6.86x | 11.28x | 12.14x | 12.14x |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 2.92x | 2.80x | 3.02x | 3.77x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Teladoc Health, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Teladoc Health, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Teladoc Health, Inc. (TDOC)?
- The EV/Sales ratio for TDOC stock is 0.65x.
- Is Teladoc Health, Inc.'s EV/Sales ratio high or low?
- Teladoc Health, Inc.'s EV/Sales ratio of 0.65x is 78% below its 5-year average of 2.92x, near the low end of its 5-year range (0.44x–19.58x).
- What is the TTM average EV/Sales ratio for Teladoc Health, Inc. (TDOC)?
- The TTM average EV/Sales ratio for TDOC stock is 0.61x.
- What is the 3Y average EV/Sales ratio for Teladoc Health, Inc. (TDOC)?
- The 3Y average EV/Sales ratio for TDOC stock is 0.88x.
- What is the 5Y average EV/Sales ratio for Teladoc Health, Inc. (TDOC)?
- The 5Y average EV/Sales ratio for TDOC stock is 1.38x.
- What is the 10Y average EV/Sales ratio for Teladoc Health, Inc. (TDOC)?
- The 10Y average EV/Sales ratio for TDOC stock is 8.14x.
Teladoc Health, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-22 | 0.65x |
| 2026-06-18 | 0.69x |
| 2026-06-17 | 0.65x |
| 2026-06-16 | 0.65x |
| 2026-06-15 | 0.65x |
| 2026-06-12 | 0.64x |
| 2026-06-11 | 0.64x |
| 2026-06-10 | 0.62x |
| 2026-06-09 | 0.61x |
| 2026-06-08 | 0.62x |
| 2026-06-05 | 0.62x |
| 2026-06-04 | 0.64x |
| 2026-06-03 | 0.62x |
| 2026-06-02 | 0.65x |
| 2026-06-01 | 0.68x |
| 2026-05-29 | 0.66x |
| 2026-05-28 | 0.65x |
| 2026-05-27 | 0.58x |
| 2026-05-26 | 0.58x |
| 2026-05-22 | 0.58x |
| 2026-05-21 | 0.58x |
| 2026-05-20 | 0.58x |
| 2026-05-19 | 0.59x |
| 2026-05-18 | 0.57x |
| 2026-05-15 | 0.57x |
| 2026-05-14 | 0.59x |
| 2026-05-13 | 0.60x |
| 2026-05-12 | 0.60x |
| 2026-05-11 | 0.61x |
| 2026-05-08 | 0.63x |
| 2026-05-07 | 0.61x |
| 2026-05-06 | 0.60x |
| 2026-05-05 | 0.59x |
| 2026-05-04 | 0.59x |
| 2026-05-01 | 0.57x |
| 2026-04-30 | 0.55x |
| 2026-04-29 | 0.52x |
| 2026-04-28 | 0.52x |
| 2026-04-27 | 0.51x |
| 2026-04-24 | 0.50x |
| 2026-04-23 | 0.50x |
| 2026-04-22 | 0.51x |
| 2026-04-21 | 0.52x |
| 2026-04-20 | 0.53x |
| 2026-04-17 | 0.50x |
| 2026-04-16 | 0.51x |
| 2026-04-15 | 0.49x |
| 2026-04-14 | 0.47x |
| 2026-04-13 | 0.47x |
| 2026-04-10 | 0.46x |
| 2026-04-09 | 0.47x |
| 2026-04-08 | 0.47x |
| 2026-04-07 | 0.47x |
| 2026-04-06 | 0.47x |
| 2026-04-02 | 0.47x |
| 2026-04-01 | 0.47x |
| 2026-03-31 | 0.48x |
| 2026-03-30 | 0.46x |
| 2026-03-27 | 0.46x |
| 2026-03-26 | 0.49x |
| 2026-03-25 | 0.49x |
| 2026-03-24 | 0.48x |
| 2026-03-23 | 0.48x |
| 2026-03-20 | 0.48x |
| 2026-03-19 | 0.49x |
| 2026-03-18 | 0.48x |
| 2026-03-17 | 0.49x |
| 2026-03-16 | 0.48x |
| 2026-03-13 | 0.48x |
| 2026-03-12 | 0.48x |
| 2026-03-11 | 0.48x |
| 2026-03-10 | 0.49x |
| 2026-03-09 | 0.47x |
| 2026-03-06 | 0.46x |
| 2026-03-05 | 0.46x |
| 2026-03-04 | 0.46x |
| 2026-03-03 | 0.46x |
| 2026-03-02 | 0.46x |
| 2026-02-27 | 0.47x |
| 2026-02-26 | 0.48x |
| 2026-02-25 | 0.45x |
| 2026-02-24 | 0.44x |
| 2026-02-23 | 0.44x |
| 2026-02-20 | 0.45x |
| 2026-02-19 | 0.46x |
| 2026-02-18 | 0.45x |
| 2026-02-17 | 0.44x |
| 2026-02-13 | 0.45x |
| 2026-02-12 | 0.44x |
| 2026-02-11 | 0.45x |
| 2026-02-10 | 0.46x |
| 2026-02-09 | 0.47x |
| 2026-02-06 | 0.47x |
| 2026-02-05 | 0.45x |
| 2026-02-04 | 0.47x |
| 2026-02-03 | 0.48x |
| 2026-02-02 | 0.50x |
| 2026-01-30 | 0.50x |
| 2026-01-29 | 0.52x |
| 2026-01-28 | 0.52x |
| 2026-01-27 | 0.54x |
| 2026-01-26 | 0.56x |
| 2026-01-23 | 0.56x |
| 2026-01-22 | 0.57x |
| 2026-01-21 | 0.55x |
| 2026-01-20 | 0.55x |
| 2026-01-16 | 0.56x |
| 2026-01-15 | 0.58x |
| 2026-01-14 | 0.58x |
| 2026-01-13 | 0.61x |
| 2026-01-12 | 0.63x |
| 2026-01-09 | 0.64x |
| 2026-01-08 | 0.65x |
| 2026-01-07 | 0.65x |
| 2026-01-06 | 0.68x |
| 2026-01-05 | 0.63x |
| 2026-01-02 | 0.61x |
| 2025-12-31 | 0.61x |
| 2025-12-30 | 0.61x |
| 2025-12-29 | 0.61x |
| 2025-12-26 | 0.62x |
| 2025-12-24 | 0.63x |
| 2025-12-23 | 0.63x |
| 2025-12-22 | 0.63x |
| 2025-12-19 | 0.63x |
| 2025-12-18 | 0.62x |
| 2025-12-17 | 0.63x |
| 2025-12-16 | 0.64x |
| 2025-12-15 | 0.63x |
| 2025-12-12 | 0.65x |
| 2025-12-11 | 0.65x |
| 2025-12-10 | 0.66x |
| 2025-12-09 | 0.66x |
| 2025-12-08 | 0.65x |
| 2025-12-05 | 0.65x |
| 2025-12-04 | 0.67x |
| 2025-12-03 | 0.65x |
| 2025-12-02 | 0.65x |
| 2025-12-01 | 0.64x |
| 2025-11-28 | 0.65x |
| 2025-11-26 | 0.64x |
| 2025-11-25 | 0.64x |
| 2025-11-24 | 0.63x |
| 2025-11-21 | 0.61x |
| 2025-11-20 | 0.59x |
| 2025-11-19 | 0.61x |
| 2025-11-18 | 0.61x |
| 2025-11-17 | 0.59x |
| 2025-11-14 | 0.61x |
| 2025-11-13 | 0.62x |
| 2025-11-12 | 0.64x |
| 2025-11-11 | 0.65x |
| 2025-11-10 | 0.65x |
| 2025-11-07 | 0.65x |
| 2025-11-06 | 0.65x |
| 2025-11-05 | 0.68x |
| 2025-11-04 | 0.68x |
| 2025-11-03 | 0.69x |
| 2025-10-31 | 0.72x |
| 2025-10-30 | 0.73x |
| 2025-10-29 | 0.71x |
| 2025-10-28 | 0.72x |
| 2025-10-27 | 0.76x |
| 2025-10-24 | 0.79x |
| 2025-10-23 | 0.73x |
| 2025-10-22 | 0.72x |
| 2025-10-21 | 0.74x |
| 2025-10-20 | 0.76x |
| 2025-10-17 | 0.73x |
| 2025-10-16 | 0.76x |
| 2025-10-15 | 0.76x |
| 2025-10-14 | 0.76x |
| 2025-10-13 | 0.71x |
| 2025-10-10 | 0.69x |
| 2025-10-09 | 0.75x |
| 2025-10-08 | 0.77x |
| 2025-10-07 | 0.72x |
| 2025-10-06 | 0.73x |
| 2025-10-03 | 0.76x |
| 2025-10-02 | 0.73x |
| 2025-10-01 | 0.68x |
| 2025-09-30 | 0.67x |
| 2025-09-29 | 0.71x |
| 2025-09-26 | 0.70x |
| 2025-09-25 | 0.69x |
| 2025-09-24 | 0.72x |
| 2025-09-23 | 0.72x |
| 2025-09-22 | 0.71x |
| 2025-09-19 | 0.69x |
| 2025-09-18 | 0.71x |
| 2025-09-17 | 0.69x |
| 2025-09-16 | 0.68x |
| 2025-09-15 | 0.67x |
| 2025-09-12 | 0.67x |
| 2025-09-11 | 0.68x |
| 2025-09-10 | 0.66x |
| 2025-09-09 | 0.68x |
| 2025-09-08 | 0.68x |
| 2025-09-05 | 0.68x |
| 2025-09-04 | 0.67x |
| 2025-09-03 | 0.68x |
| 2025-09-02 | 0.67x |
| 2025-08-29 | 0.67x |
| 2025-08-28 | 0.69x |
| 2025-08-27 | 0.68x |
| 2025-08-26 | 0.68x |
| 2025-08-25 | 0.67x |
| 2025-08-22 | 0.67x |
| 2025-08-21 | 0.64x |
| 2025-08-20 | 0.64x |
| 2025-08-19 | 0.65x |
| 2025-08-18 | 0.66x |
| 2025-08-15 | 0.66x |
| 2025-08-14 | 0.64x |
| 2025-08-13 | 0.65x |
| 2025-08-12 | 0.62x |
| 2025-08-11 | 0.61x |
| 2025-08-08 | 0.62x |
| 2025-08-07 | 0.62x |
| 2025-08-06 | 0.62x |
| 2025-08-05 | 0.62x |
| 2025-08-04 | 0.62x |
| 2025-08-01 | 0.62x |
| 2025-07-31 | 0.64x |
| 2025-07-30 | 0.65x |
| 2025-07-29 | 0.67x |
| 2025-07-28 | 0.71x |
| 2025-07-25 | 0.71x |
| 2025-07-24 | 0.71x |
| 2025-07-23 | 0.74x |
| 2025-07-22 | 0.73x |
| 2025-07-21 | 0.72x |
| 2025-07-18 | 0.70x |
| 2025-07-17 | 0.70x |
| 2025-07-16 | 0.69x |
| 2025-07-15 | 0.69x |
| 2025-07-14 | 0.72x |
| 2025-07-11 | 0.72x |
| 2025-07-10 | 0.76x |
| 2025-07-09 | 0.76x |
| 2025-07-08 | 0.73x |
| 2025-07-07 | 0.70x |
| 2025-07-03 | 0.72x |
| 2025-07-02 | 0.72x |
| 2025-07-01 | 0.74x |
| 2025-06-30 | 0.75x |
| 2025-06-27 | 0.73x |
| 2025-06-26 | 0.70x |
| 2025-06-25 | 0.67x |
| 2025-06-24 | 0.70x |
| 2025-06-23 | 0.69x |
| 2025-06-20 | 0.62x |
| 2025-06-18 | 0.63x |
| 2025-06-17 | 0.64x |
| 2025-06-16 | 0.63x |
| 2025-06-13 | 0.62x |
| 2025-06-12 | 0.64x |
| 2025-06-11 | 0.66x |
| 2025-06-10 | 0.66x |
| 2025-06-09 | 0.66x |
Showing the most recent 260 of 2,760 data points. The chart above shows the full history.
Related Metrics
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita